Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | piromidic acid | 4855 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | piromidic acid | 4855 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | piromidic acid | 4855 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | piromidic acid | 4855 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | piromidic acid | 4855 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | piromidic acid | 4855 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | theobromine | 5757 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | theobromine | 5757 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | theobromine | 5757 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | theobromine | 5757 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | theobromine | 5757 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | theobromine | 5757 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | theobromine | 5757 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | theobromine | 5757 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | theobromine | 5757 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | Prestwick-864 | None | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | Prestwick-864 | None | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | Prestwick-864 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-864 | None | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | Prestwick-864 | None | drug-path |